EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Irisin and Metastatic Melanoma: Selective Anti-Invasiveness Activity in BRAF Wild-Type Cells

Simona Serratì iD, Roberta Zerlotin, Michele Manganelli iD, Roberta Di Fonte iD, Manuela Dicarlo, Angela Oranger, Graziana Colaianni, Letizia Porcelli, Amalia Azzariti iD, Stefania Guida iD, Maria Grano iD, Silvia Concetta Colucci und 1 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26020652 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Simona Serratì und 12 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Istituto Tumori Giovanni Paolo II, 70124 Bari, Italy. Hauptthemen laut MEDLINE: Fibronectins, Proto-Oncogene Proteins B-raf, Melanoma. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Regione Puglia and CNR for Tecnopolo per la Medicina di Precisione. D.G.R. n. 2117 of 21.11.2018, C.I.R.E.M.I.C. (Research Center of Excellence for Neurodegenerative Diseases and Brain Aging) - University of Bari "Aldo Moro" - Investment PE8-Project Age-It:…, Regione Puglia and CNR for Tecnopolo per la Medicina di Precisione. D.G.R. n. 2117 of 21.11.2018 (CUPB84I18000540002)—C.I.R.E.M.I.C. (Research Center of Excell….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Irisin is a newly discovered 12 kDa messenger protein involved in energy metabolism. Irisin affects signaling pathways in several types of cancer; however, the role of irisin in metastatic melanoma (MM) has not been described yet. We explored the biological effects of irisin in in vitro models of MM cells (HBLwt/wt, LND1wt/wt, Hmel1V600K/wt and M3V600E/V600E) capable of the oncogenic activation of BRAF. We treated MM cells with different concentrations of r-irisin (10 nM, 25 nM, 50 nM, 100 nM) for 24 h–48 h. An MTT assay highlighted that r-irisin did not affect the proliferation of MM cells. We subsequently treated MM cells with 10 nM r-irisin, corresponding to the dose exhibiting biological activity in vitro. Irisin reduced the invasive ability of only LND1wt/wt (p < 0.05), which highly expressed αv gene levels, but did not affect the invasion of BRAFmut cells. Gelatin zymography analysis showed a reduction in the enzymatic activity of MMP-2 and MMP-9 in BRAFwt/wt cells treated with 10 nM r-irisin. Moreover, gene expression analysis (qPCR) of MMP-2 and MMP-9 and of the fibrinolytic system (uPAR, uPA and PAI-1) highlighted a crucial role of 10 nM r-irisin treatment in the inhibition of pro-invasive systems in BRAFwt/wt. In conclusion, our results may suggest a possible differential role of irisin in melanoma cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibronectinsProto-Oncogene Proteins B-rafMelanomaHumansCell Line, TumorCell ProliferationMatrix Metalloproteinase 2Matrix Metalloproteinase 9Neoplasm InvasivenessGene Expression Regulation, NeoplasticCell MovementNeoplasm Metastasis

Stichwörter der Autor:innen

BRAFMMPsfibrinolytic systemirisinmelanomamyokine

Substanzen

FibronectinsProto-Oncogene Proteins B-rafBRAF protein, humanFNDC5 protein, humanMatrix Metalloproteinase 2Matrix Metalloproteinase 9

Autor:innen und Institutionen

  • IRCCS Istituto Tumori Giovanni Paolo II, 70124 Bari, Italy.
  • Department of Precision and Regenerative Medicine and Ionian Area, University of Bari, 70124 Bari, Italy.
  • Department of Translational Biomedicine and Neuroscience, University of Bari, 70124 Bari, Italy.
  • School of Medicine, Vita-Salute San Raffaele University, 20132 Milan, Italy.
  • Dermatology Clinic, IRCCS San Raffaele Hospital, 20132 Milan, Italy.

ORCID-Profile: Simona Serratì, Michele Manganelli, Roberta Di Fonte, Amalia Azzariti, Stefania Guida, Maria Grano, Gabriella Guida

Förderung

  • Regione Puglia and CNR for Tecnopolo per la Medicina di Precisione. D.G.R. n. 2117 of 21.11.2018
  • C.I.R.E.M.I.C. (Research Center of Excellence for Neurodegenerative Diseases and Brain Aging) - University of Bari "Aldo Moro" - Investment PE8-Project Age-It:…
  • Regione Puglia and CNR for Tecnopolo per la Medicina di Precisione. D.G.R. n. 2117 of 21.11.2018 (CUPB84I18000540002)—C.I.R.E.M.I.C. (Research Center of Excell…
  • Investment PE8—Project Age-It: “Ageing Well in an Ageing Society”

Zitieren

APA

Serratì, S., Zerlotin, R., Manganelli, M., Di Fonte, R., Dicarlo, M., Oranger, A., Colaianni, G., Porcelli, L., Azzariti, A., Guida, S., Grano, M., Colucci, S. C., & Guida, G. (2025). Irisin and Metastatic Melanoma: Selective Anti-Invasiveness Activity in BRAF Wild-Type Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26020652

Vancouver

Serratì S, Zerlotin R, Manganelli M, Di Fonte R, Dicarlo M, Oranger A, et al. Irisin and Metastatic Melanoma: Selective Anti-Invasiveness Activity in BRAF Wild-Type Cells. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26020652

BibTeX
@article{Serrat2025,
  author = {Serratì, Simona and Zerlotin, Roberta and Manganelli, Michele and Di Fonte, Roberta and Dicarlo, Manuela and Oranger, Angela and Colaianni, Graziana and Porcelli, Letizia and Azzariti, Amalia and Guida, Stefania and Grano, Maria and Colucci, Silvia Concetta and Guida, Gabriella},
  title = {Irisin and Metastatic Melanoma: Selective Anti-Invasiveness Activity in BRAF Wild-Type Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26020652}
}
Kostenlos starten →